Why is this test performed?
- To diagnose Ataxia-Telangiectasia in individuals with movement disorders.
- To assess the hereditary risk of developing specific cancers.
- To screen family members for carrier status of the ATM mutation.
This genetic screening identifies ATM gene mutations, providing crucial insights into Ataxia-Telangiectasia diagnosis and hereditary cancer risks. It empowers families with the knowledge needed for proactive healthcare and specialized preventative strategies.
Scientific name: Ataxia-Telangiectasia (ATM) Genetic Screening
A molecular test analyzing the ATM gene to diagnose Ataxia-Telangiectasia and assess hereditary predispositions to various cancers, including breast and pancreatic malignancies, ensuring early intervention.